Stay updated with breaking news from Total Identity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment analysts at StockNews.com initiated coverage on shares of Conformis (NASDAQ:CFMS – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the medical instruments supplier’s stock. Separately, Oppenheimer downgraded shares of Conformis from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May […]
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our […]
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered Conformis from an outperform rating to a market perform rating in a research report on Tuesday, May 9th. View Our […]
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Monday. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our Latest […]
StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. View Our […]